◆英語タイトル:genedrive plc (GDR) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8012829
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月29日
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
genedrive plc (GDR) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
genedrive plc (genedrive), formerly Epistem Holdings plc is a molecular diagnostics company. The company focuses on the development and commercialization of simple to use “point of need” system or point of care diagnostics platform for the diagnosis of infectious diseases and use in patient genotyping, pathogen detection and other indications. It also provides contract research services novel and transferable preclinical models and services to support decision making throughout the drug discovery and development pipeline to other pharmaceutical companies, as well as GCLP accredited gene expression and genotype analysis for drug development and diagnostic programs. genedrive is headquartered in Manchester, the UK.
genedrive plc Key Recent Developments
Nov 08,2017: Genedrive chief operating officer Allan Brown to step down
Nov 08,2017: genedrive: Directorate Change
Oct 17,2017: Genedrive Announces its audited Preliminary Results for the year ended 30 June 2017
Jul 27,2017: genedrive Awarded Additional $1.4m Funding by US Department of Defense to Continue Development of Genedrive as a Handheld Biohazard Identifier
Mar 30,2017: Genedrive: Interim Results for the six month period to 31 December 2016
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
genedrive plc – Key Facts 6
genedrive plc – Key Employees 7
genedrive plc – Key Employee Biographies 8
genedrive plc – Major Products and Services 9
genedrive plc – History 10
genedrive plc – Company Statement 13
genedrive plc – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
genedrive plc – Business Description 15
genedrive plc – Corporate Strategy 16
genedrive plc – SWOT Analysis 17
SWOT Analysis – Overview 17
genedrive plc – Strengths 17
genedrive plc – Weaknesses 18
genedrive plc – Opportunities 19
genedrive plc – Threats 20
genedrive plc – Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios – Capital Market Ratios 22
Financial Ratios – Annual Ratios 23
Performance Chart 25
Financial Performance 25
Financial Ratios – Interim Ratios 26
Financial Ratios – Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
genedrive plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28
genedrive plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29
genedrive plc, Recent Deals Summary 30
Section 5 – Company’s Recent Developments 31
Nov 08, 2017: genedrive: Directorate Change 31
Oct 17, 2017: Genedrive Announces its audited Preliminary Results for the year ended 30 June 2017 32
Jul 27, 2017: genedrive Awarded Additional $1.4m Funding by US Department of Defense to Continue Development of Genedrive as a Handheld Biohazard Identifier 36
Mar 30, 2017: Genedrive: Interim Results for the six month period to 31 December 2016 37
Jan 16, 2017: genedrive Reports Delivery of Genedrive Units and Assays to the US Department of Defense in Programme to Develop a Handheld Biohazard Identifier 38
Nov 29, 2016: genedrive: Update on CFO Appointment 39
Oct 11, 2016: Genedrive Announces Preliminary Results for the year ended 30 June 2016 40
Sep 21, 2016: Genedrive Announces Appointment of Chief Financial Officer 45
Jul 25, 2016: Epistem Holdings Announces Re change of name, TIDM and website address 46
Jul 11, 2016: Epistem Holdings Announces Result of General Meeting and Change of Name 47
Section 6 – Appendix 48
Methodology 48
Ratio Definitions 48
About GlobalData 52
Contact Us 52
Disclaimer 52
List of Tables
genedrive plc, Key Facts 6
genedrive plc, Key Employees 7
genedrive plc, Key Employee Biographies 8
genedrive plc, Major Products and Services 9
genedrive plc, History 10
genedrive plc, Subsidiaries 14
genedrive plc, Key Competitors 21
genedrive plc, Ratios based on current share price 22
genedrive plc, Annual Ratios 23
genedrive plc, Annual Ratios (Cont...1) 24
genedrive plc, Interim Ratios 26
genedrive plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28
genedrive plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29
genedrive plc, Recent Deals Summary 30
Currency Codes 48
Capital Market Ratios 48
Equity Ratios 49
Profitability Ratios 49
Cost Ratios 50
Liquidity Ratios 50
Leverage Ratios 51
Efficiency Ratios 51